Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sebastian Schröpf"'
Autor:
Rima Snariene, Hans Georg Münch, Anne Smits, Christopher M. Rubino, Arunas Liubsys, Karine Litherland, Tomasz Tomasik, Kamal Hamed, Dace Gardovska, Chi D. Hornik, Mark J Polak, Przemko Kwinta, Veerle Cossey, Sebastian Schröpf, Christine Ruehle, Miroslava Bosheva
Publikováno v:
The Pediatric Infectious Disease Journal
Pediatric infectious disease journal, Philadelphia : Lippincott Williams and Wilkins, 2021, vol. 40, no. 11, p. 997-1003
Pediatric infectious disease journal, Philadelphia : Lippincott Williams and Wilkins, 2021, vol. 40, no. 11, p. 997-1003
Supplemental Digital Content is available in the text.
Background: Ceftobiprole, the active moiety of the prodrug ceftobiprole medocaril, is an advanced-generation, broad-spectrum, intravenous cephalosporin, which is currently approved for the t
Background: Ceftobiprole, the active moiety of the prodrug ceftobiprole medocaril, is an advanced-generation, broad-spectrum, intravenous cephalosporin, which is currently approved for the t
Autor:
Sebastian Schröpf, Anthony P. Cammarata, Kamal Hamed, Mark J Polak, Karine Litherland, Anne Smits, Christopher M. Rubino
Publikováno v:
Antimicrobial Agents and Chemotherapy
Ceftobiprole is an advanced-generation cephalosporin for intravenous administration with activity against Gram-positive and Gram-negative organisms. A population pharmacokinetic (PK) model characterizing the disposition of ceftobiprole in plasma usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93df92573d8679313762b166f149487a
https://lirias.kuleuven.be/handle/123456789/683977
https://lirias.kuleuven.be/handle/123456789/683977
Autor:
Uwe Liebchen, Sebastian Michel, Johannes Zander, Ann Katrin Denninger, Nikolaus Kneidinger, Ines Schroeder, Michael Vogeser, Christina Scharf, Michael Zoller, Michael Paal, Luis Ilia, Sebastian Schröpf, Charlotte Kloft, Carina Schuster, Ferdinand Weinelt, Christian Schneider
Publikováno v:
Antimicrob Agents Chemother
Pneumonia is one of the most common infections in intensive care patients, and it is often treated with beta-lactam antibiotics. Even if therapeutic drug monitoring in blood is available, it is unclear whether sufficient concentrations are reached at